Volume 87 Issue 37 | p. 19 | Concentrates
Issue Date: September 14, 2009

Targeted Genetics Has Deal With Genzyme

Department: Business
Keywords: biotechnology, Targeted Genetics, Genzyme

Targeted Genetics has sold manufacturing and other technology related to adeno-associated viral vectors to Genzyme for up to $7 million. Genzyme licensed the technology back to the Seattle-based firm for use in specified drug discovery programs. Since November 2008, Targeted Genetics has reduced its workforce by 80% to 15 employees. CEO B. G. Susan Robinson says the company now has enough cash to continue operating through 2010.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment